Chronic Total Occlusion Registry

N/ATerminatedNCT04041921

Seung-Jung Park4,006 enrolled

Overview

This study evaluated the long-term outcome of patients with chronic total occlusion treated with percutaneous coronary intervention, medical treatment or coronary artery bypass grafting.

This study is connected with Decision-CTO trial(NCT01078051). Randomized subjects and registry group subjects from Decision-CTO trial continue 10 years follow-up on this study.

Study Type

OBSERVATIONAL

Enrollment

4,006

Conditions

Coronary Occlusion Coronary Artery Stenosis Coronary Stenosis

Interventions

Percutaneous coronary interventionPROCEDURE

Coronary Artery Bypass GraftingPROCEDURE

Medical treatmentDRUG

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with angina or silent ischemia and documented ischemia * Patients with De novo chronic coronary occlusion ≥ 3months and reference diameter ≥ 2.5 mm on coronary angiography * Age \> 18 years Exclusion Criteria: * Refuse to participate in this study

Locations (19)

SAM hospital

Anyang, South Korea

Soon Chun Hyang University Hospital Bucheon

Bucheon-si, South Korea

Outcomes

Primary Outcomes

Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization

Time frame: 10 years

Secondary Outcomes

Event rate of all cause death

Time frame: 10 years

Event rate of acute myocardial infarction

Time frame: 10 years

Event rate of stroke

Time frame: 10 years

Event rate of repeat revascularization

Time frame: 10 years

Event rate of rehospitalization due to acute coronary syndrome

Time frame: 10 years

The rate change of left ventricular ejection fraction

Time frame: 10 years

Composite event of death, myocardial, stroke or repeat revascularization

Time frame: 5 years

Composite event of death, myocardial, stroke or repeat revascularization

Time frame: 10 years

Event rate of Procedural success

Procedural success is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization.

Time frame: 5 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.